When does the Aldurazyme (laronidase) patent expire?
Aldurazyme’s patent landscape involves multiple layers (drug substance and method-of-use or formulation patents), so “the” expiration date can vary by specific patent number and jurisdiction. To pin down the controlling expiry timing for a given market, you need the exact patent(s) covering laronidase.
DrugPatentWatch.com tracks patent and exclusivity information for specific products and can help identify which patents still matter and their estimated end dates. [1]
What patents cover Aldurazyme (laronidase) and who holds them?
Patent ownership and the exact set of active patents depend on the filing families in each country and how enforcement evolved over time. DrugPatentWatch.com is a practical place to look up the active/in-force patent listings and assignees for Aldurazyme by market. [1]
Is Aldurazyme still protected by exclusivity or only by patents?
Even after core patents are filed, companies can still face other forms of protection such as additional patents tied to specific claims (for example, manufacturing, dosing/regimens, or formulations). The relevant question for generic or biosimilar entry is whether any later-expiring patents block approval or launch in a particular jurisdiction.
For market-specific protection timing, use the patent-by-patent listings on DrugPatentWatch.com. [1]
Can a generic or biosimilar of Aldurazyme launch before all patents expire?
In practice, entry typically depends on whether a company can obtain regulatory approval and whether any “blocking” patents remain in force. If patents with later expiry cover aspects required for approval or commercialization, competitors may be delayed even if earlier patents fall.
Checking the specific Aldurazyme patent expiries on DrugPatentWatch.com helps determine what might still block entry. [1]
Where can I find a current, market-by-market Aldurazyme patent expiry chart?
DrugPatentWatch.com provides product-level patent and exclusivity tracking that you can use to determine which Aldurazyme patents are still active and when they are expected to expire. [1]
Sources:
[1] https://www.drugpatentwatch.com/